Research reported that C/EBPα (CCAAT/enhancer-binding protein) and C/EBPα-p30 could negatively regulate lncRNA UCA1 expression by binding to the promoter and highly expressed AML cases with cytogenetically normal and carrying biallelic CEBPA mutation. This evidence concerns the gene CEBPA and acute myeloid leukemia.